Drug Shortage Report for TEVA-FLUVASTATIN

Last updated on 2021-11-25 History
Report ID 139731
Drug Identification Number 02299224
Brand name TEVA-FLUVASTATIN
Common or Proper name FLUVASTATIN 20MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FLUVASTATIN
Strength(s) 20MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-05-19
Estimated end date 2021-12-31
Actual end date
Shortage status Actual shortage
Updated date 2021-11-25
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-11-25 French Compare
v11 2021-11-25 English Compare
v10 2021-10-21 French Compare
v9 2021-10-21 English Compare
v8 2021-09-23 French Compare
v7 2021-09-23 English Compare
v6 2021-08-13 French Compare
v5 2021-08-13 English Compare
v4 2021-07-29 French Compare
v3 2021-07-29 English Compare
v2 2021-05-20 French Compare
v1 2021-05-20 English Compare